Evidence map›Paper›PMID 40370326›Full record

ArticleAdvanced healthcare materials2025

Fabrication of a Lipopolysaccharide-Targeting Peptide-Based Colloid for Alleviating Carbapenem-Resistant Enterobacteriaceae-Induced Cutaneous Infection.

Ping Zeng, Xinyi Ding, Chenyu Liu, Sheng Chen, Kin-Fai Chan, Sharon Shui Yee Leung

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ping ZengSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China.
Xinyi DingSchool of Pharmacy, Fudan University, Shanghai, 201203, China.
Chenyu LiuDepartment of Food Science and Nutrition, Faculty of Science, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
Sheng ChenDepartment of Food Science and Nutrition, Faculty of Science, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
Kin-Fai ChanState Key Laboratory of Chemical Biology and Drug Discovery and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
Sharon Shui Yee LeungSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China.ORCID 0000-0002-0194-7058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) becomes a growing threat to human health. Many clinical isolates have shown strong resistance to commonly used antibacterial agents. Inspired by cationic amphiphiles with tandem-repeat sequence, two novel peptides termed IW (IWRRIWRRIWRRIWRR-NH

Indexed as

Anti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsLipopolysaccharidesPeptidesAnimalsEscherichia coliHumansLarvaMiceMicrobial Sensitivity TestsMothsPoloxamerAnti-Bacterial AgentsLipopolysaccharidesPeptidesPoloxamercationic peptideLPS‐targetingmembrane‐activemolecular dynamics simulationmultidrug‐resistance bacteriaskin abrasion

Identifiers

PMID40370326
PMCPMC12184079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.